Trial Better Live: Trial Continuity During COVID-19


Join us for the first Trial Better Live question and answer session, where industry experts share their thoughts on the challenges clinical trial sponsors face in keeping their trials on track during the COVID-19 pandemic.

Trial Better Live offers an interactive forum for the clinical research community to engage with industry experts and discuss:

  • What are the biggest endpoint data collection challenges facing clinical trial sponsors?
  • How can sponsors and service / technology providers collaborate to achieve clinical development goals? 
  • What is this pandemic teaching us about the industry’s dependence on patient access to investigative sites?
  • How can sponsors prepare for virtual trials now (and after) COVID-19?

To take part in this valuable, engaging experience, please join us on April 16 at 11 AM EST/ 15:00 GMT.



FEATURED GUEST



KEN FAULKNER

Webinar Moderator & Vice President, Clinical Science & Consulting
ERT


JIM MUNZ

Vice President, Product Management
ERT


KEN KAITIN

Director, Tufts Center for the Study of Drug Development
TUFTS UNIVERSITY


LAURENT SCHOCKMEL

CEO
ANTIDOTE